CardioBites Plus: Amyloidosis - Mechanism of Disease

Overview - What are CardioBites+

Building on the success of the CardioBites Series, the CardioBites + Video Series is designed to take learning to the next level, offering expanded microlearning content that is both accessible and impactful for physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in heart failure. They can be watched anytime, anywhere on YouTube. No password. No barriers. Just easy access. Look below for CardioBites+ topics.

CardioBites+: Amyloidosis - Mechanism of Disease

The majority of cardiac amyloidosis is caused by 2 proteins and is classified as either amyloid light-chain (AL) amyloidosis or transthyretin amyloidosis (ATTR). Join us for this discussion of the different mechanisms of disease and why understanding these differences may impact management decisions for these patients.

Target Audience

The CardioBites Video Series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in Heart Failure.

Future Series Outline

CardioBites+: Amyloidosis - Diagnosis
CardioBites+: Amyloidosis - Treatment/Management

CardioBites+ FAQs

CardioBites+ FAQs

Please visit our post-module evaluation survey as well!
Link to survey: https://www.surveymonkey.com/r/8RL5D9K

Visit our website: https://hfsa.org/cardiobitesplus

HFSA YouTube Channel

View the full video series: YouTube

Supporter(s)

The Heart Failure Society of America acknowledges Alnylam Pharmaceuticals for providing an independent educational grant to support the HFSA CardioBites+: Amyloidosis series.

Summary

Cost:

FREE

Credit:

No Credit Offered

Create Account